BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30092450)

  • 1. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
    McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
    Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using inducible lentiviral vectors to generate induced pluripotent stem cell line ZOCi001-A from peripheral blood cells of a patient with CRB1
    Tang X; Liu X; Chen Z; Luo L; Liu X; Deng J; Li DW; Liu Y
    Stem Cell Res; 2020 May; 45():101817. PubMed ID: 32387899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants.
    Zhang X; Thompson JA; Zhang D; Charng J; Arunachalam S; McLaren TL; Lamey TM; De Roach JN; Jennings L; McLenachan S; Chen FK
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1489. PubMed ID: 32931148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
    Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
    Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene.
    Zhou Y; Ding C; Xia S; Jing Y; Mao S; Liu J; Chen J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 Apr; 44():101742. PubMed ID: 32244200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier.
    McLenachan S; Zhang D; Zhang X; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Fletcher S; Chen FK
    Stem Cell Res; 2019 Jan; 34():101357. PubMed ID: 30611018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.
    Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2018 May; 29():245-249. PubMed ID: 29753273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200.
    Zhang D; McLenachan S; Chen SC; Zaw K; Alziyadat Y; Zhang X; Lamey TM; Thompson JA; McLaren TL; Mellough C; De Roach JN; Chen FK
    Stem Cell Res; 2021 Mar; 51():102154. PubMed ID: 33429167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoids.
    Buck TM; Quinn PMJ; Pellissier LP; Mulder AA; Jongejan A; Lu X; Boon N; Koot D; Almushattat H; Arendzen CH; Vos RM; Bradley EJ; Freund C; Mikkers HMM; Boon CJF; Moerland PD; Baas F; Koster AJ; Neefjes J; Berlin I; Jost CR; Wijnholds J
    Stem Cell Reports; 2023 Sep; 18(9):1793-1810. PubMed ID: 37541258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy.
    Claassen JN; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 Jan; 34():101352. PubMed ID: 30634128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4.
    Jennings L; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2020 Oct; 48():101947. PubMed ID: 32810830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
    Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of CRB1 RP Patient-Derived iPSCs and a CRISPR/Cas9-Mediated Homology-Directed Repair Strategy for the CRB1 c.2480G>T Mutation.
    da Costa BL; Li Y; Levi SR; Tsang SH; Quinn PMJ
    Adv Exp Med Biol; 2023; 1415():571-576. PubMed ID: 37440088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene.
    Bai X; Chen J; Zhao X; Zhu X; Ding X; Zhang T; Jiang M; Sun X
    Stem Cell Res; 2024 Jun; 77():103390. PubMed ID: 38507880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.